402 related articles for article (PubMed ID: 26028173)
1. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
[TBL] [Abstract][Full Text] [Related]
2. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic therapy for acute heart failure.
Tang WH
Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
[TBL] [Abstract][Full Text] [Related]
4. Nesiritide for the treatment of congestive heart failure.
Iyengar S; Feldman DS; Trupp R; Abraham WT
Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for acute decompensated heart failure.
Southworth MR
Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
DeWald TA; Hernandez AF
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Saltzberg MT
Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
[TBL] [Abstract][Full Text] [Related]
9. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
[TBL] [Abstract][Full Text] [Related]
10. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
Dandamudi S; Chen HH
Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
[TBL] [Abstract][Full Text] [Related]
11. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
Noviasky JA
Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
[TBL] [Abstract][Full Text] [Related]
12. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
Yancy CW
Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
[TBL] [Abstract][Full Text] [Related]
13. Hospital policies for treatment of acute decompensated heart failure.
Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
[TBL] [Abstract][Full Text] [Related]
14. Nesiritide: trials and tribulations.
Arora RR
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
[TBL] [Abstract][Full Text] [Related]
15. Nesiritide: a review of its use in acute decompensated heart failure.
Keating GM; Goa KL
Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
[TBL] [Abstract][Full Text] [Related]
16. Nesiritide: harmful or harmless?
Dorsch MP; Rodgers JE
Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
[TBL] [Abstract][Full Text] [Related]
17. [Natriuretic peptides in the therapy of acute decompensated heart failure].
Gassanov N; Caglayan E; Erdmann E; Er F
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1738-43. PubMed ID: 21877307
[TBL] [Abstract][Full Text] [Related]
18. Critical review and recommendations for nesiritide use in the emergency department.
Collins SP; Hinckley WR; Storrow AB
J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
[TBL] [Abstract][Full Text] [Related]
19. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
Ezekowitz JA; Hernandez AF; Starling RC; Yancy CW; Massie B; Hill JA; Krum H; Diaz R; Ponikowski P; Metra M; Howlett JG; Gennevois D; O'Connor CM; Califf RM; Fonarow GC
Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
